Karyopharm Therapeutics Inc. Retained Earnings
Karyopharm Therapeutics Inc. (KPTI) had Retained Earnings of -$1.85 billion as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.85B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.78B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.76B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.66B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$1.85B 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$1.78B 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$1.76B 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$1.66B 10-Q · filed 2025-11-03 |
| 2025-06-30 | -$1.62B 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$1.59B 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$1.56B 10-K · filed 2026-02-13 |
| 2024-09-30 | -$1.53B 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$1.50B 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$1.52B 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$1.49B 10-K · filed 2025-02-19 |
| 2023-09-30 | -$1.45B 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$1.41B 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$1.38B 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$1.34B 10-K · filed 2024-02-29 |
| 2022-09-30 | -$1.31B 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$1.27B 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$1.22B 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$1.18B 10-K · filed 2023-02-17 |
| 2021-09-30 | -$1.22B 10-Q · filed 2021-11-03 |
| 2021-06-30 | -$1.17B 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$1.11B 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$1.07B 10-K · filed 2022-03-01 |
| 2020-09-30 | -$1.03B 10-Q · filed 2020-11-02 |
| 2020-06-30 | -$972.70M 10-Q · filed 2020-08-04 |
| 2020-03-31 | -$926.27M 10-Q · filed 2020-05-05 |
| 2019-12-31 | -$873.34M 10-K · filed 2021-02-24 |
| 2019-09-30 | -$824.69M 10-Q · filed 2019-11-04 |
| 2019-06-30 | -$783.32M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$739.91M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$673.75M 10-K · filed 2020-02-26 |
| 2018-09-30 | -$615.54M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$567.45M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$533.80M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$495.34M 10-K · filed 2019-02-28 |
| 2017-09-30 | -$456.30M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$425.66M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$396.27M 10-Q · filed 2017-05-04 |
| 2016-12-31 | -$366.10M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$339.17M 10-Q · filed 2016-11-07 |
| 2016-06-30 | -$313.74M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$283.59M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$256.53M 10-K · filed 2017-03-16 |
| 2015-09-30 | -$227.48M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$197.11M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$164.41M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$138.35M 10-K · filed 2016-03-15 |
| 2013-12-31 | -$62.57M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |